PENK and hydrops fetalis: Recent literature has shed light on a so far neglected biomarker, proenkephalin 119–159 (PENK119–159), which belongs to the enkephalin family of endogenous opioid peptides (EOPs) and has been shown to predict adverse outcomes in patients with HF [2].